Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
====================================================================================================================================================

* Michelle H. Nelson
* Jacob S. Bowers
* Stefanie R. Bailey
* Marshall A. Diven
* Caroline W. Fugle
* Andrew D. M. Kaiser
* Claudia Wrzesinski
* Bei Liu
* Nicholas P. Restifo
* Chrystal M. Paulos